Snowflake Inc. 833445109 US8334451098 07/02/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES 134.000000 0 FOR 134.000000 FOR STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2025. SECTION 14A SAY-ON-PAY VOTES 1530.000000 0 FOR 1530.000000 FOR KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 4768712.000000 0 FOR 4768712.000000 FOR Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES 2463.000000 0 FOR 2463.000000 FOR Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES 2600.000000 0 AGAINST 2600.000000 AGAINST Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 60.000000 0 FOR 60.000000 FOR Tesla, Inc. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation. SECTION 14A SAY-ON-PAY VOTES 41149.000000 0 AGAINST 41149.000000 AGAINST Oracle Corporation 68389X105 US68389X1054 11/18/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 64430.000000 0 AGAINST 64430.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/19/2025 Approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 54.000000 0 FOR 54.000000 FOR Benitec Biopharma Inc. 08205P209 US08205P2092 12/01/2025 Approval of the non-binding advisory vote on the compensation of the Company's named executive officers as disclosed in the attached proxy statement. SECTION 14A SAY-ON-PAY VOTES 9647827.000000 0 FOR 9647827.000000 FOR Ferguson Enterprises Inc. 31488V107 US31488V1070 12/03/2025 To approve, on an advisory basis, the fiscal 2025 compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 261783.000000 0 FOR 261783.000000 FOR Microsoft Corporation 594918104 US5949181045 12/05/2025 Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote") SECTION 14A SAY-ON-PAY VOTES 77643.000000 0 FOR 77643.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 560.000000 0 FOR 560.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the ""Compensation Proposal""). SECTION 14A SAY-ON-PAY VOTES 94100.000000 0 AGAINST 94100.000000 AGAINST Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 12488.000000 0 FOR 12488.000000 FOR Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 4990.000000 0 FOR 4990.000000 FOR Life Time Group Holdings, Inc. 53190C102 US53190C1027 04/22/2026 To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 24349.000000 0 FOR 24349.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1.000000 0 FOR 1.000000 FOR Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES 98786.000000 0 FOR 98786.000000 FOR Abbott Laboratories 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES 23373.000000 0 FOR 23373.000000 FOR Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 8597649.000000 0 FOR 8597649.000000 FOR Revvity, Inc. 714046109 US7140461093 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES 6.000000 0 FOR 6.000000 FOR W.W. Grainger, Inc. 384802104 US3848021040 04/29/2026 To approve on a non-binding, advisory basis the compensation of Grainger's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 8935.000000 0 FOR 8935.000000 FOR Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 Ferguson Enterprises Inc. 31488V107 US31488V1070 04/30/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025. SECTION 14A SAY-ON-PAY VOTES 101934.000000 0 FOR 101934.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 1891.000000 0 FOR 1891.000000 FOR Bank of America Corporation 060505104 US0605051046 05/04/2026 Approving our executive compensation (an advisory, non-binding ""Say on Pay"" resolution) SECTION 14A SAY-ON-PAY VOTES 682261.000000 0 FOR 682261.000000 FOR West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 18.000000 0 FOR 18.000000 FOR Baxter International Inc. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES 1.000000 0 FOR 1.000000 FOR Danaher Corporation 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 173806.000000 0 FOR 173806.000000 FOR GE Aerospace 369604301 US3696043013 05/05/2026 Advisory Approval of Our Named Executives' Compensation SECTION 14A SAY-ON-PAY VOTES 310258.000000 0 FOR 310258.000000 FOR Talen Energy Corporation 87422Q109 US87422Q1094 05/05/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 MGM Resorts International 552953101 US5529531015 05/06/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 163952.000000 0 FOR 163952.000000 FOR Stryker Corporation 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES 1021.000000 0 FOR 1021.000000 FOR Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES 18700.000000 0 FOR 18700.000000 FOR Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES 87.000000 0 FOR 87.000000 FOR Capital One Financial Corporation 14040H105 US14040H1059 05/08/2026 Advisory vote on our Named Executive Officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES 154799.000000 0 FOR 154799.000000 FOR Vulcan Materials Company 929160109 US9291601097 05/08/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 24845.000000 0 FOR 24845.000000 FOR Advanced Micro Devices, Inc. 007903107 US0079031078 05/13/2026 Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in the proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission. SECTION 14A SAY-ON-PAY VOTES 110733.000000 0 FOR 110733.000000 FOR Veralto Corporation 92338C103 US92338C1036 05/13/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 5475.000000 0 FOR 5475.000000 FOR Repligen Corporation 759916109 US7599161095 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES 111.000000 0 FOR 111.000000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 US Foods Holding Corp. 912008109 US9120081099 05/14/2026 Advisory approval of the compensation paid to our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 41082.000000 0 FOR 41082.000000 FOR Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 8.000000 0 FOR 8.000000 FOR Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 8.000000 0 ONE YEAR 8.000000 FOR Align Technology, Inc. 016255101 US0162551016 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 712.000000 0 FOR 712.000000 FOR Amazon.com, Inc. 023135106 US0231351067 05/20/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES 254009.000000 0 FOR 254009.000000 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES 1.000000 0 FOR 1.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 621.000000 0 AGAINST 621.000000 AGAINST Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 138.000000 0 FOR 138.000000 FOR Bruker Corporation 116794108 US1167941087 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 4.000000 0 FOR 4.000000 FOR The Home Depot, Inc. 437076102 US4370761029 05/21/2026 Advisory Vote to Approve Executive Compensation ("Say-on-Pay") SECTION 14A SAY-ON-PAY VOTES 36528.000000 0 FOR 36528.000000 FOR Waters Corporation 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES 50.000000 0 FOR 50.000000 FOR Wingstop Inc. 974155103 US9741551033 05/21/2026 Approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation (""Say on Pay""). SECTION 14A SAY-ON-PAY VOTES 45.000000 0 FOR 45.000000 FOR DexCom, Inc. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES 31680.000000 0 FOR 31680.000000 FOR Roblox Corporation 771049103 US7710491033 05/28/2026 Advisory Vote on the Compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 0.000000 0 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 100630.000000 0 FOR 100630.000000 FOR Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 16700.000000 0 FOR 16700.000000 FOR Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 16700.000000 0 ONE YEAR 16700.000000 FOR Astera Labs, Inc. 04626A103 US04626A1034 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers (""NEOs"") as disclosed in our proxy materials. SECTION 14A SAY-ON-PAY VOTES 4166.000000 0 FOR 4166.000000 FOR Astera Labs, Inc. 04626A103 US04626A1034 06/04/2026 To approve, on an advisory basis, the frequency of holding future advisory votes to approve the compensation of our NEOs. SECTION 14A SAY-ON-PAY VOTES 4166.000000 0 ONE YEAR 4166.000000 FOR Capricor Therapeutics, Inc. 14070B309 US14070B3096 06/04/2026 APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES 1760405.000000 0 FOR 1760405.000000 FOR Capricor Therapeutics, Inc. 14070B309 US14070B3096 06/04/2026 APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ONA NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES 1760405.000000 0 ONE YEAR 1760405.000000 FOR Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers (""Say-on-Pay""), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 6267394.000000 0 FOR 6267394.000000 FOR Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES 6267394.000000 0 ONE YEAR 6267394.000000 FOR Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 11785519.000000 0 FOR 11785519.000000 FOR Apollo Global Management, Inc. 03769M106 US03769M1062 06/08/2026 An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay); SECTION 14A SAY-ON-PAY VOTES 346088.000000 0 AGAINST 346088.000000 AGAINST Apollo Global Management, Inc. 03769M106 US03769M1062 06/08/2026 An advisory vote on the frequency of future advisory votes to approve the compensation of AGM's named executive officers (Say on Frequency); and SECTION 14A SAY-ON-PAY VOTES 346088.000000 0 ONE YEAR 346088.000000 AGAINST Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 4.000000 0 FOR 4.000000 FOR Trulieve Cannabis Corp. 89788C104 CA89788C1041 06/09/2026 Advisory (Non-Binding) vote on the compensation of the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES 356100.000000 0 FOR 356100.000000 FOR Compass Therapeutics, Inc. 20454B104 US20454B1044 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 9430768.000000 0 FOR 9430768.000000 FOR Compass Therapeutics, Inc. 20454B104 US20454B1044 06/10/2026 To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 9430768.000000 0 ONE YEAR 9430768.000000 FOR Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1173366.000000 0 FOR 1173366.000000 FOR Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1173366.000000 0 ONE YEAR 1173366.000000 FOR Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 3605278.000000 0 FOR 3605278.000000 FOR Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 10100.000000 0 FOR 10100.000000 FOR Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 10100.000000 0 ONE YEAR 10100.000000 FOR Whitehawk Therapeutics, Inc. 00032Q104 US00032Q1040 06/11/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the ""Executive Compensation"" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES 3700000.000000 0 FOR 3700000.000000 FOR Abeona Therapeutics Inc. 00289Y206 US00289Y2063 06/12/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2553916.000000 0 FOR 2553916.000000 FOR Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES 450906.000000 0 FOR 450906.000000 FOR EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES 8228529.000000 0 FOR 8228529.000000 FOR Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 6463818.000000 0 FOR 6463818.000000 FOR NVIDIA Corporation 67066G104 US67066G1040 06/24/2026 Advisory approval of our executive compensation. SECTION 14A SAY-ON-PAY VOTES 538090.000000 0 FOR 538090.000000 FOR Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 801097.000000 0 FOR 801097.000000 FOR